Movement disorders : official journal of the Movement Disorder Society · 2004
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
СтатьяПоддержка исследования: вне правительства СШАВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wenning Gregor K, Tison François, Seppi Klaus, Sampaio Cristina, Diem Anja, Yekhlef Farid, Ghorayeb Imad, Ory Fabienne, Galitzky Monique, Scaravilli Tommaso, Bozi Maria, Colosimo Carlo, Gilman Sid, Shults Clifford W, Quinn Niall P, Rascol Olivier, Poewe Werner, Multiple System Atrophy Study Group
Аннотация
We aimed to develop and validate a novel rating scale for multiple system atrophy (Unified Multiple System Atrophy Rating Scale-UMSARS). The scale comprises the following components: Part I, historical, 12 items; Part II, motor examination, 14 items; Part III, autonomic examination; and Part IV, global disability scale. For validation purposes, 40 MSA patients were assessed in four centers by 4 raters per center (2 senior and 2 junior raters). The raters applied the UMSARS, as well as a range of other scales, including the Unified Parkinson's Disease Rating Scale (UPDRS) and the International Cooperative Ataxia Rating Scale (ICARS). Internal consistency was high for both UMSARS-I (Crohnbach's alpha = 0.84) and UMSARS-II (Crohnbach's alpha = 0.90) sections. The interrater reliability of most of the UMSARS-I and -II items as well as of total UMSARS-I and -II subscores was substantial (k(w) = 0.6-0.8) to excellent (k(w) > 0.8). UMSARS-II correlated well with UPDRS-III and ICARS (rs > 0.8). Depending on the degree of the patient's disability, completion of the entire UMSARS took 30 to 45 minutes. Based on our findings, the UMSARS appears to be a multidimensional, reliable, and valid scale for semiquantitative clinical assessments of MSA patients.
Предметные рубрики MeSH
Activities of Daily LivingAge of OnsetAutonomic Nervous SystemCerebellar AtaxiaDisability EvaluationErectile DysfunctionFemaleHumansHypotension, OrthostaticMaleMultiple System AtrophyObserver VariationParkinsonian DisordersReproducibility of ResultsSeverity of Illness IndexSpeech DisordersSurveys and QuestionnairesUrinary IncontinenceUrinary Retention